Subject preference comparison between Clobetasol propionate shampoo, 0.05% and three other topical corticosteroids in the treatment of moderate to severe Scalp psoriasis.

Trial Profile

Subject preference comparison between Clobetasol propionate shampoo, 0.05% and three other topical corticosteroids in the treatment of moderate to severe Scalp psoriasis.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 21 Dec 2011

At a glance

  • Drugs Betamethasone dipropionate/salicylic acid; Betamethasone valerate; Clobetasol
  • Indications Psoriasis
  • Focus Therapeutic Use
  • Sponsors Galderma
  • Most Recent Events

    • 21 Dec 2011 Lead trial investigator (Alberto Giannetti) identified as reported by ClinicalTrials.gov.
    • 21 Dec 2011 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT00438399).
    • 30 Aug 2011 This trial is recruiting in United Kingdom and Germany and has completed in Italy.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top